Value of next generation sequencing (NGS) testing in advanced cancer patients.

Jesse D Ortendahl Gebra Cuyun Carter Snehal G Thakkar Katalin Bognar David W Hall Yara G Abdou

Published in: Journal of medical economics (2024)

Compared to single-gene testing, results indicate that using next generation sequencing test such as OncoExTra identified more actionable alterations, leading to improved outcomes and reduced costs.

Keyphrases

copy number
circulating tumor
genome wide
type diabetes
dna methylation
metabolic syndrome
genome wide identification
insulin resistance
glycemic control
cell free